Page last updated: 2024-10-22

am 580 and Endometrial Neoplasms

am 580 has been researched along with Endometrial Neoplasms in 2 studies

Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.

Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, YH1
Utsunomiya, H2
Pavone, ME1
Yin, P1
Bulun, SE1
Tanabe, K1
Tamura, M1
Niikura, H1
Takano, T1
Yoshinaga, K1
Nagase, S1
Suzuki, T1
Ito, K1
Matsumoto, M1
Hayashi, S1
Yaegashi, N1

Other Studies

2 other studies available for am 580 and Endometrial Neoplasms

ArticleYear
Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms.
    Journal of molecular endocrinology, 2011, Volume: 46, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Benzoates; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Endom

2011
Expression of retinoic acid receptors in human endometrial carcinoma.
    Cancer science, 2008, Volume: 99, Issue:2

    Topics: Antineoplastic Agents; Benzoates; Carcinoma; Cell Proliferation; Endometrial Hyperplasia; Endometria

2008